Re-evaluating over-the-counter options for acute pain management

Misuse of analgesics has become a major concern in recent years, leading to the upscheduling of codeine in 2018, modified-release paracetamol in 2020, and now further potential changes to paracetamol access in 2024. These regulatory changes are obviously important for curbing negative trends—but while attempting to minimise the risk of harms, is there also a